TURSG:BISTTurkiye Sigorta A.S. Analysis
Data as of 2026-06-17 - not real-time
TRY 6.47
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Türkiye Sigorta A.S. trades at a significantly low price relative to its intrinsic valuation, with a discounted cash‑flow estimate suggesting a substantial upside. The company’s earnings multiple is well below the industry average, and its dividend yield is attractive while the payout ratio remains comfortably low, indicating sustainable cash returns.
On the technical front, the stock sits just above its short‑term moving average but below the medium‑term average, with a bullish MACD crossover and rising volume, hinting at possible momentum building toward the next resistance zone. The current price is near a clear support level, offering a margin of safety for new positions.
Risk considerations include elevated short‑term volatility and exposure to Turkey‑specific macro and regulatory dynamics, yet the stock’s beta is minimal and liquidity is strong. Given the strong profitability metrics, robust cash position, and under‑priced valuation, the outlook remains favorable across horizons.
On the technical front, the stock sits just above its short‑term moving average but below the medium‑term average, with a bullish MACD crossover and rising volume, hinting at possible momentum building toward the next resistance zone. The current price is near a clear support level, offering a margin of safety for new positions.
Risk considerations include elevated short‑term volatility and exposure to Turkey‑specific macro and regulatory dynamics, yet the stock’s beta is minimal and liquidity is strong. Given the strong profitability metrics, robust cash position, and under‑priced valuation, the outlook remains favorable across horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Undervaluation relative to DCF and peers
- Bullish MACD signal with increasing volume
- Support level providing downside protection
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and high operating margins
- Robust return on equity and low leverage
- Sustainable dividend with ample cash coverage
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑term upside potential from significant valuation gap
- Consistent profitability and cash generation
- Solid market position in Turkey's non‑life insurance sector
Key Metrics & Analysis
Financial Health
Revenue Growth29.20%
Profit Margin22.90%
P/E Ratio6.0
ROE49.39%
ROA11.79%
Debt/Equity0.24
P/B Ratio1.3
Op. Cash FlowTRY4.2B
Free Cash FlowTRY-14267836416
Industry P/E17.1
Technical Analysis
TrendNeutral
RSI48.0
SupportTRY 6.05
ResistanceTRY 6.77
MA 20TRY 6.37
MA 50TRY 6.76
MA 200TRY 6.07
MACDBullish
VolumeIncreasing
Fear & Greed Index92.43
Valuation
Fair ValueTRY 10.45
Target PriceTRY 9.52
Upside/Downside47.19%
GradeUndervalued
TypeBlend
Dividend Yield2.29%
Risk Assessment
Beta0.00
Volatility52.92%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.